ARNOLD & PORTER KAYE SCHOLER LLP

Lobbying for SPYRE THERAPEUTICS, INC. · Biotechnology company focused on treatments for gastrointestinal and rheumatic diseases.

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · Massachusetts · House · Senate · $10,000.00 income · posted Jan 15, 2026

Lobbying activity 1

Health Issues

Issues related to monoclonal antibody products.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.